Happy sailing, "Bebig"!
Rusnano announces the withdrawal from the capital of the portfolio company "Bebig" – the only Russian manufacturer of micro sources for low-dose brachytherapy of prostate cancer.
15.10.2015Rusnano announces the withdrawal from the capital of the portfolio company "Bebig" – the only Russian manufacturer of micro sources for low-dose brachytherapy of prostate cancer.
15.10.2015Biopharmaceuticals and biomedicine are considered to be the most attractive segment of the biotechnological market for investment.
14.10.2015The examples of Celgene, Genzyme and Monsanto show how innovative strategies can pay off.
12.10.2015Scientists of the Institute of Organic Chemistry have developed the concept of API-IL (active pharmaceutical ingredient – ionic liquid) to achieve structural diversity in pharmaceuticals, as well as the creation of dual-acting drugs.
12.10.2015Biotechnologist and plant physiologist from UrFU Alexander Yermoshin debunks myths about the harm of genetically modified vegetables and talks about Christmas trees in test tubes and about which plant can save soils contaminated with heavy metals.
09.10.2015The motto of the forum this year is "Ahead of tomorrow". In parallel with the Innovation Forum, the Expoforum hosts the exhibition "Russian Industrialist".
08.10.2015Preclinical trials of the drug "Diphag", acting on two types of microorganisms that most often cause infections in patients of surgical hospitals, as well as intensive care units and intensive care units, have been completed.
08.10.2015As part of a partnership with the Japanese research center RIKEN, the Kazan company "Eidos-Medicine" will open a simulation center, which has seven robot simulators for laparoscopic, endovascular, hysteroscopic and endourological interventions.
06.10.2015In addition to spinal cord injury therapy, gene-cell technologies can be used to treat injuries of the peripheral nervous system, neurodegenerative diseases, ischemic diseases and lesions of the musculoskeletal system.
06.10.2015About how mr. Shkreli acquired the rights to the drug daraprim and immediately raised the price for it 55 times and about the reaction of American society to this, from doctors and their patients to the presidential candidate.
05.10.2015The director of the analytical department of the IC "Golden Hills – Capital AM" advises not to acquire firms of a low degree of reliability, but in time-tested securities of companies with a total value of shares over $ 100 billion.
02.10.2015A strontium vapor laser, invented by scientists at Tomsk State University, can be used for cutting and drilling living bone.
25.09.2015The list of 500 leaders of Russian business includes 23 companies operating in the pharmaceutical market, 10 of them are pharmaceutical distributors.
25.09.2015Hillary Clinton in her microblog on Twitter promised to present a plan to combat the increase in drug prices. After this statement, the index of biotech companies traded on the Nasdaq stock exchange fell by 4.7%.
23.09.2015A laboratory of structural bioinformatics and molecular modeling is being opened at the Faculty of Natural Sciences of Novosibirsk State University.
21.09.2015Despite the more applied economic nature of the third international forum of Central Bankers-2015, many scientists take part in its work.
18.09.2015A fundamentally new chip based on graphene oxide allows testing drugs outside of a living organism. Technology can revolutionize the creation of new drugs and help doctors defeat incurable diseases in the near future.
18.09.2015The biopharmaceutical funding boom continues. In the first half of 2015, investors invested more money in these areas than in the whole of 2013.
16.09.2015The Center for Fundamental and Applied Problems of bioecology and Biotechnology of UGPI plans to use the obtained cellular products in clinics for more effective treatment of burns, ulcers, mechanical injuries of the skin.
15.09.2015Last year, the shares of companies at the preliminary testing stage or in Phase 1 on the first day of trading grew by an average of 29%. The situation is somewhat reminiscent of the famous dot-com bubble, when stocks soared by 50-70% on the first day of trading
14.09.2015You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.